These medications act through multiple metabolic mechanisms and may be considered as part of a personalized treatment approach guided by clinical assessment and ongoing monitoring
At present, the main GLP-1RAs drugs that have been marketed include liraglutide, exenatide, albiglutide and dulaglutide ( The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Osteoporosis Effects of Glucagon-Like Peptide-1 Receptor Agonists on Diabetic Osteoporosis Most patients with T2DM have normal bone density, but the risk of fracture is increased
Adams JB, Garver CR et al
What matters is whether the lesion is benign (which it almost always is) and what triggered it
Also, be cautious if they sell from social media
En el estudio SURMOUNT-1, los participantes con obesidad o sobrepeso tratados con tirzepatida 15 mg lograron una prdida de peso promedio del 22.5% despus de 72 semanas